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Mulefoot disease (MFD) is an autosomal recessive disorder of phenotypically variable expression that causes syndactyly in certain strains of
cows. MFD maps to a narrow interval on bovine chromosome 15 that is syntenic to human chromosome 11p12–p11.2. This region contains
MEGF7/LRP4 (approved gene symbol LRP4), a gene that encodes a member of the multifunctional low-density lipoprotein receptor gene
family. Targeted and naturally occurring mutations in the murine Megf7/Lrp4 gene, a putative coreceptor in the Wnt signaling pathway, cause
polysyndactyly in the rodent. Thus, Megf7/Lrp4 is a strong candidate for the MFD mutation. Using PCR analysis of tissue samples and sperm
from confirmed homozygous MFD carriers, we have identified a functional single base pair mutation in the affected animals. We show that a G→
A transition at the first nucleotide in the splice donor site of intron 37 completely disables this splice site. The abnormal splicing that is caused by
this mutation predicts the generation of a dysfunctional membrane-anchored receptor lacking the normal cytoplasmic domain. These findings
confirm that autosomal recessive loss-of-function mutations in Megf7/Lrp4 result in phenotypically similar forms of syndactyly in different
mammalian species and that such mutations are the cause of MFD in bovines.
© 2006 Elsevier Inc. All rights reserved.Keywords: Apical ectodermal ridge; LDL receptor family; Wnt; Syndactyly; Lipoprotein receptorSyndactylies and polysyndactylies, malformations of the
distal limbs that result in fusion with or without the presence
of supernumerary digits, are not uncommon and occur in a
number of etiologically distinct genetic syndromes in humans
[1]. A number of naturally occurring mutations that cause
similar syndromes have also been identified in rodents and
other species [2]. In particular the advent of gene knockout
technology has yielded an increasing number of mutant mouse
strains that comprise the entire spectrum of limb deformities
[3,4].
A naturally occurring form of autosomal recessive syndac-
tyly with variable penetrance in the bovine species, termed
mulefoot disease (MFD), results in the painful fusion of the
hooves and reduced mobility. It occurs in several valuable
strains known for meat or milk production, including Angus,
Holsteins, and Friesians [5–7]. As few as one and up to all four⁎ Corresponding author.
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doi:10.1016/j.ygeno.2006.08.005hooves may be abnormally fused in homozygous carriers of the
disease, suggesting that the syndrome is caused by one or more
hypomorphic mutations in a single gene and that the range of
phenotypic expression may be modulated by other genetic or
epigenetic factors. Heterozygous female carriers of MFD have
been reported to show increased milk production, which could
explain the selection for and persistence of the mutant allele in
the cow population [6–8].
Through identity-by-descent analysis, and owing to the
detailed records of pedigreesmaintained by commercial breeders
for the Angus, Holstein, and Dutch black-and-white Friesian
populations, the monogenic autosomal recessive MFD trait has
been mapped to bovine chromosome 15 [5,8]. This chromo-
some is almost entirely contained within human chromosome
11 [9], making it highly likely that the human ortholog to the
bovine MFD gene resides on this chromosome.
We and others have previously reported that loss-of-function
mutations in the Megf7/Lrp4 gene (approved gene symbol
Lrp4) result in an autosomal recessive form of polysyndactyly
601E.B. Johnson et al. / Genomics 88 (2006) 600–609in the mouse [10,11]. Megf7/Lrp4 encodes a member of the
multifunctional low-density lipoprotein (LDL) receptor gene
family [12,13]. Expression analysis of misregulated or abnor-
mally expressed genes involved in the control of limb
development combined with in vitro reporter gene experiments
suggested that Megf7/Lrp4 can regulate Wnt signaling and that
it may also be involved in the control of bone morphogenetic
protein (Bmp), fibroblast-like growth factor, and sonic hedge-
hog (Shh) signals. Potential roles in Bmp [14] and Shh signaling
[15] have previously been proposed for Megalin, another LDL
receptor family member, and the highly homologous Lrp1 can
antagonize Wnt signaling in vitro [16]. Moreover, the structural
organization of the extracellular domain of Megf7/Lrp4 closely
resembles that of Lrp5/6, two related receptors that function as
coreceptors for Wnt in the canonical Wnt signaling pathway
[17–19]. Taken together, these findings make it likely that
Megf7/Lrp4 controls the formation of the mammalian limbs by
serving as a coreceptor or modulator of one or more of these
morphogenic signals.
MFD maps to a narrow interval on bovine chromosome 15
that is syntenic to human chromosome 11p12–p11.2 and mouse
chromosome 2. A lod score of 24.3 links the chromosomal
marker BM848 to the MFD locus [8]. Megf7/Lrp4 lies within
this region, making it a strong candidate for the MFD mutation.
Using PCR analysis of tissue samples and sperm from
confirmed homozygous MFD carriers, we have identified a
single functional base pair mutation in two affected animals.
We show that a G → A transition at the first nucleotide in the
splice donor site of intron 37 of Megf7/Lrp4 disrupts this splice
site. The abnormal splicing that is caused by this mutationFig. 1. Megf7/Lrp4 is closely linked to marker BM848 on bovine chromosome 15.
from data collected from the NCBI (http://www.ncbi.nih.gov), Ensembl (http://ww
from Charlier et al. [8] and Gautier et al. [9]. Bovine Megf7/Lrp4 is separated by 2.1
TGLA75 and BM848 are markers shown by Charlier at al. [8] to be linked to MFDpredicts the generation of a dysfunctional membrane-anchored
receptor that lacks its normal cytoplasmic domain. Low
residual functional activity of this truncated receptor, or
variable generation of small amounts of a normal splice
product, might explain the individual phenotypic variability of
MFD.
Results
Megf7/Lrp4 resides within the MFD region
Naturally occurring [11] and experimentally induced [10]
loss-of-function mutations in the murine Megf7/Lrp4 gene
result in an autosomal recessive phenotype that includes a fully
penetrant form of polysyndactyly of fore- and hind limbs and
incompletely penetrant facial dysmorphisms that include
defects in tooth development [10]. Syndactyly syndromes in
humans are common and genetically heterogeneous, and none
of the known human autosomal recessive syndactyly syndromes
have been mapped to chromosome 11p12–p11.2, where
Megf7/Lrp4 resides. By contrast, an autosomal recessive form
of syndactyly in the cow, known as MFD, has been mapped to
bovine chromosome 15, which is almost in its entirety syntenic
to human chromosome 11 [9]. The MFD locus has been mapped
to the vicinity of the chromosomal marker BM848, which is in
linkage disequilibrium with MFD with an extremely high lod
score of 24.3 [8].Megf7/Lrp4 resides within 2.1 Mb of BM848
(Fig. 1), and in light of its known biological functions and
genetic properties it is an obvious and prime candidate for
MFD.Comparative schematic of human chromosome 11 and bovine chromosome 15
w.ensembl.org), and USDA MARC (http://www.marc.usda.gov) databases and
Mb from BM848, the marker linked to MFD with the highest lod score (24.3).
.
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To determine whether genetic mutations that disrupt the
function of the bovine Megf7/Lrp4 gene are present in MFD
carriers we have analyzed the genomic sequence at the Megf7/
Lrp4 locus of two known homozygous MFD carriers (Fig. 2),
using tissue samples obtained from one of the affected animals
(MF1) and frozen sperm from another (MF2). PCR primers were
designed and used to amplify most of the Megf7/Lrp4 coding
region, including flanking intronic sequences (described under
Experimental procedures). Several independently obtained
wild-type samples were used as controls. No functionally
predictable sequence differences were found between MFD and
wild-type samples, except at a single nucleotide position at the
exon/intron boundary 37 (Fig. 2A). Both MFD samples (MF1
and MF2) differed from wild type at the first nucleotide of the
splice donor site, where the normally occurring “GT” sequence
was changed to “AT”. “GT” at this position is highly conserved
among splice sites. Moreover, G→ A mutations in splice donor
sites at this position have been shown to severely cripple or
completely abrogate splicing [20]. This finding suggests that in
the two affected disease carriers we have examined MFD is
caused by the disruption of Megf7/Lrp4 pre-mRNA splicing.
The site of the mutation at exon/intron boundary 37 is locatedFig. 2. A G→ A mutation disrupts the 5′ splice site of intron 37 in the Angus mulefo
bovine exon 37. In wild type (left) the first base of intron 37 is G. In the mulefoot sam
star indicates the mutated base. The underlined nucleotides are the intronic bases that b
Vertical lines represent exons. The first 35 exons encode the extracellular domain
cytoplasmic domain of Megf7/Lrp4. The mulefoot mutation occurs at the first baseimmediately downstream of the first exon encoding cytoplasmic
domain sequences ofMegf7/Lrp4 (Fig. 2B), suggesting that the
MFD phenotype is caused either by destabilization of the
transcript or by exon skipping and abnormal truncation of the
translation product, or both.
The G → A splice site mutation prevents normal splicing
To demonstrate that the single point mutation we have found
in exon/intron boundary 37 does indeed abrogate the normal
splicing of Megf7/Lrp4, and that the resulting transcript would
thus result in an abnormal and dysfunctional translation product,
we cloned exon 37 including approximately 200 bp of flanking
upstream and downstream intronic sequences into the splicing
test vector pcAT7. This vector is an artificial minigene consisting
of the β-actin promoter and a fragment of the β-globin gene that
has been engineered to facilitate fusion to heterologous intronic
and exonic sequences [21]. The structure of the test vector/
minigene is shown in Fig. 3A. Two splicing test vectors were
generated, one that contained the indicated wild-type bovine
sequences (cloned between the NdeI and the HindIII sites) and
another one that was identical except for the single point
mutation at the exon/intron 37 boundary. Wild-type (pcAT7-
WT), mutant (pcAT7-MF), and empty (pcAT7-SC12) vectorsot allele of bovineMegf7/Lrp4. (A) The sequence of the 3′ exon/intron border of
ples (right) this, in splice sites, highly conserved G is mutated to A. The purple
ind to U1 RNA. (B) Graphic representation of the bovineMegf7/Lrp4 sequence.
. Exon 36 encodes the transmembrane domain. Exons 37 and 38 encode the
of intron 37.
Fig. 3. Minigene splicing analysis of the mulefoot mutation. (A) Diagram of the primary unspliced product of the minigene. Bovine exon 37 and 200 bp of flanking
intronic sequence was cloned between the first and the second exon of the β-globin minigene using the restriction enzymes NdeI and HindIII. The only difference
between the wild-type and mulefoot minigene constructs is the G-to-A mulefoot mutation (red) at the first residue of intron 37. (B) Both exon 37 and flanking introns
fail to splice in the mulefoot minigene RNA. Transcripts from the transfected minigene constructs were reverse-transcribed and amplified by PCR using the indicated
Act and Ge3R primers. The regions of the minigene that generated the observed products are indicated on the left and these splice products were verified by
sequencing. (Lanes 1–3) Mulefoot sequence (MF), (lanes 4–6) wild-type sequence (WT), (lane 7) parental pcAT7-SC12 plasmid, (lane 8) untransfected cells. (C)
Expected MF-Megf7/Lrp4 translation product. Wild-type sequence is shown at the top, MF sequence (including intron 36) below.
603E.B. Johnson et al. / Genomics 88 (2006) 600–609were transfected into HEK293 cells, and the resulting transcripts
were analyzed by RT-PCR using the indicated primers Act
(forward) and GE3R (reverse), as described previously [22]. Fig.
3B shows the RT-PCR products that were isolated from multiple
independently transfected culture dishes at different days after
transfection and subjected to agarose gel analysis and sequen-
cing. Splicing was not affected by the time at which the cells
were harvested after transfection. As shown in lanes 1–3, MF
sequences did not undergo productive splicing and instead
yielded a single high-molecular-weight transcript, which
resulted from the inclusion of the upstream as well as
downstream introns together with exon 37 (uppermost splice
product i, present in lanes 1 and 3). Splicing of the pre-mRNA
did occur, however, since the normal globin intron present in this
construct (intron 3) was quantitatively removed and absent fromall products, as confirmed by sequencing of the PCR products.
By contrast, the wild-type test construct (lanes 4–6) was
efficiently spliced to the expected product (ii, middle), with no
detectable long form (i) remaining. Two cryptic or incomple-
tely spliced intermediate products (indicated by the asterisks)
were also detected, as often occurs in such minigene assays
[22]. Transfection with the control vector (lane 7) yielded the
expected product (iii, lower band).
Aberrant splicing of intron 36 in MFD
Megf7/Lrp4 is expressed postnatally in various tissues,
including the brain, kidney, lung, stomach, etc. (our own
unpublished results). However,Megf7/Lrp4 transcripts were not
detectable in the sperm samples (sperm generally does not
604 E.B. Johnson et al. / Genomics 88 (2006) 600–609contain mRNA), and only very low levels were detectable by
RT-PCR in the skin. To investigate whether the Megf7/Lrp4
transcript is misspliced in vivo, as predicted by our in vitro
splicing assay, we performed RT-PCR on wild-type and MFD
RNA isolated from the skin sample using the primers indicated
in Fig. 4. Primers located in exons 30 (forward) and 36 (reverse)
were used as controls to demonstrate normal splicing of exons
upstream of the MFD mutation and yielded the expected
product, which was identical in the wild type and in the MFD
samples (Fig. 4B). To detect unspliced intron 36 sequences we
used another primer pair, consisting of a forward primer in exon
35 and a reverse primer in intron 37. The latter was chosen
instead of a primer in exon 38, since intron 37 is too large for
effective amplification and thus did not allow us to demonstrate
the presence of aberrantly spliced products containing this intron
in MFD. We thus had to rely instead on the presence of nuclear
hnRNA in which intron 37 had not yet been spliced in wild-typeFig. 4. RT-PCR analysis of wild-type and MFD Megf7/Lrp4 RNA. (A) Structure of t
mutation is shown in red. Forward primers in exons 30 and 35 and reverse primers in
PCR products including exon 30–36 sequences are obtained from wild-type and M
sample, is obtained when exon 35 and intron 37 primers are used. (C) Incomplete sp
Partial inclusion of intron 36 is predicted to replace the wild-type cytoplasmic domain
Sequence of the cytoplasmic domain of bovineMegf7/Lrp4. The NPXYmotif, which
highlighted in orange. A YXXL endocytosis motif [25] is highlighted in purple. Thand MFD samples. Fig. 4B reveals the presence of a single RT-
PCR product in the wild-type RNA and a single longer product
in MFD. Sequencing of both bands revealed a wild-type product
from which introns 35 and 36 had been normally spliced. By
contrast, intron 36 was aberrantly spliced in the MFD sample,
resulting in the use of a cryptic splice acceptor site and partial
inclusion of this intron. This in vivo result confirms our findings
in the in vitro splicing assay and shows that the single point
mutation in the splice donor site of intron 37 interferes with the
normal splicing of the upstream intron 36.
Taken together, the results from this in vitro splicing analysis
show that splicing of the primary Megf7/Lrp4 transcript at
intron 36/exon 37 as well as exon 37/intron 37 is completely
prevented by the single nucleotide substitution that is present in
the MFD alleles, with the normal splice product being
completely undetectable. This splicing defect results in the
partial inclusion of intron 36 in the final transcript (Fig. 4C).he Megf7/Lrp4 gene ranging from exon 30 to 38. The location of the splice site
exon 36 and intron 37 are indicated by arrows. (B) Normal and equivalent RT-
FD mRNA, while a longer product, indicating incomplete splicing of the MFD
licing of intron 36 in MFD Megf7/Lrp4 mRNAwas confirmed by sequencing.
of Megf7 with 17 missense amino acids followed by a premature stop codon. (D)
is important for the function of other LDL receptor gene family members [23], is
e PDZ-domain binding consensus sequence is highlighted in green.
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anchored in the plasma membrane through its normal
transmembrane segment, which is encoded in its entirety by
exon 36. However, the entire normal cytoplasmic domain of
Megf7/Lrp4 would be missing, since the sequences encoding
this domain would be replaced by 17 missense amino acids
resulting from the inclusion of the partially unspliced intron 36.Fig. 5. Yeast two-hybrid clones interact with functional domains in the cytoplasmi
cytoplasmic domain of Megf7 as the bait plasmid against a brain cDNA library (prey
least two functional domains within the Megf7 cytoplasmic tail. (A) Clones containi
cytoplasmic domain. Deletion of the entire PDZ binding consensus sequence (left)
interactions (right). (B) CAPON is a PTB domain-containing protein that binds to the
either the NPSY motif (middle) or the three upstream amino acids (TYS) (left) with al
PTB domain adapter protein that binds to several members of the LDL receptor gene
bind to Megf7/Lrp4 (left) in a yeast two-hybrid mating experiment. Interactions are r
β-galactosidase, which converts X-gal to a blue dye. ARIP2, activin receptor-interactin
Lin-7 type 2 (gb∣BC031780.1); PSD-95, presynaptic density protein 95 (sp∣Q6210
SemaF cytoplasmic domain-associated protein 1 (gb∣BC003490.1); CAPON, C-termFig. 4D shows the amino acid sequence of the cytoplasmic
domain of bovine Megf7/Lrp4 and the predicted site of
truncation in MFD. Highlighted are predicted functional
sequence motifs that would be missing in the mutant protein.
The “NPSY” sequence (orange) can serve as an endocytosis
sequence [23] as well as a docking site for phosphotyrosine-
binding (PTB) domain adapter proteins [24]. “YXXL” motifsc tail of Megf7/Lrp4. A yeast two-hybrid screen was performed using the full
library). Mutational analysis shows that clones identified in this screen bind to at
ng PDZ domains bind to the carboxyl-terminal amino acids of the Megf7/Lrp4
or only the carboxyl-terminal valine (middle) disrupts PDZ domain-dependent
NPXY motif of several LDL receptor gene family members [27]. Substitution of
anines disrupts the binding of CAPON to wild-typeMegf7/Lrp4 (right). Dab1, a
family [27], interacts with the Megalin cytoplasmic domain (right) but does not
evealed by the growth of yeast on minimal medium, as well as the expression of
g protein 2 (gb∣AF414433.1); LIN-7, mouse homolog ofCaenorhabditis elegans
8); SERBIN, similar to Erbb2-interacting protein (gb∣AAH28256.1); Synectin,
inal PDZ domain ligand of neuronal nitric oxide synthase (gb∣AAC4065.1).
606 E.B. Johnson et al. / Genomics 88 (2006) 600–609(purple) can also serve as endocytosis motifs that couple cell-
surface receptors of the LDL receptor gene family to the
endocytosis machinery [25], and the SESQV sequence meets
the consensus for a PDZ domain protein docking motif.
Functional interaction motifs in the cytoplasmic domain of
Megf7/Lrp4
Using a yeast two-hybrid approach we have shown that the
“NPSY” and “SESQV” motifs can indeed specifically interact
with intracellular adaptor and scaffolding proteins that contain
PDZ (ARIP2, LIN-7, PSD-95, SERBIN, Synectin) or PTB
domains (CAPON) (Fig. 5). Mutations of critical residues within
the consensus motif, e.g., complete deletion of the SESQVmotif
or deletion of only the carboxyl-terminal valine (SESQ) in the
PDZ domain binding motif, eliminated binding of the identified
PDZ motif binding proteins (Fig. 5A). Similarly, mutations of
Megf7/Lrp4 cytoplasmic domain residues that interact with
critical side chains within the PTB domain binding groove [26]
eliminated the ability of the tail sequences to interact with the
PTB domain protein CAPON (Fig. 5B). PTB domain proteins do
not interact indiscriminately with “NPXY”motifs [24]. The PTB
domain protein Dab1 interacts specifically with Megalin,
another LDL receptor family member [27]. However, Dab1
did not interact with Megf7/Lrp4 sequences (bottom).
Discussion
We have found a single point mutation in a splice site of
Megf7/Lrp4 in homozygous carriers of MFD, a syndactyly
disorder in cows and an economic concern for breeders and meat
producers. We have shown that the G → A substitution in the
first nucleotide of the highly conserved “GT” core that
constitutes splice donor sites in most mammalian exon/intron
boundaries prevents the generation of a normal Megf7/Lrp4
mRNA.As a result of either transcript instability or translation of
an abnormally truncated product, or a combination of both, the
production of a normal Megf7/Lrp4 gene product would be
virtually abolished. The resulting phenotype closely matches
that seen in naturally occurring or experimentally induced
mutations in this gene and thus strongly supports our conclusion
thatMFD in the cow is also caused by loss-of-functionmutations
in the Megf7/Lrp4 gene.
Samples from two known affected homozygousMFD carriers
were available to us for direct genomic sequence analysis of
Megf7/Lrp4: a skin sample from a recently deceased and
clinically confirmed case ofMFD and frozen sperm from another
clinically confirmed animal, both belonging to the Angus strain
of cattle. PCR analysis of exons and flanking intronic sequences
was achieved using primers located within the introns, based on
the bovine genomic sequence in the Ensembl database.
Comparison of the exon sequences with those obtained from
wild-type control samples or the Ensembl database did not reveal
any differences. However, when we analyzed the exon/intron
boundaries, we discovered a single point mutation in the first
nucleotide of the donor splice site of intron 37. Similar G→ A
mutations have been described in other genetic diseases in whichthey have been shown to be responsible for the genetic defects by
disrupting the normal splicing of the gene [20,28].
To demonstrate that the primary Megf7/Lrp4 transcript is
indeed misspliced in the homozygous carriers we used a
minigene-based splicing assay that is routinely used to study
the functionality and efficiency of splice sites to determine how
this single nucleotide substitution might alter the splicing of the
transcript. The substitution of A for G at the first nucleotide of an
intron abolishes the interaction of the splicing machinery with
the 5′ end of the intron and prevents use of this splice site [29].
Moreover, splicing to the upstream 3′ splice site on the other side
of the exon is also typically inhibited by such mutations due to a
loss of exon definition [20,30]. Based on these earlier studies,
the G → A substitution in Megf7/Lrp4 would be predicted to
cause either skipping of exon 37 (i.e., splicing of exon 36 to 38)
or retention of introns 36 and 37. The results from our minigene
splicing experiment unambiguously show that in the Megf7/
Lrp4 case the G → A substitution causes retention of both
introns 36 and 37 (Fig. 3B). This observation is consistent with
studies that have suggested that certain exons contain sequences
that inhibit their skipping [31] and provides a naturally occurring
and biomedically relevant example of such a phenomenon.
Aberrant splicing resulting in the partial retention of intron 36
was also confirmed by RT-PCR analysis of the MFD skin
sample. The mRNA that would result from retention of introns
36 and 37 in Megf7/Lrp4 would be predicted to encode a
truncated Megf7 protein that remains anchored in the plasma
membrane, but that completely lacks its normal cytoplasmic
domain. This domain contains several sequence motifs that are
known to activate intracellular signaling pathways through
interaction with cytoplasmic adapter proteins [32], as well as
endocytosis signals that can mediate the internalization of the
normal protein and its recycling back to the cell surface.
This finding reveals two potential mechanisms, both of which
on their own or in combination could severely cripple or
completely abrogate Megf7 function and thus disrupt normal
limb development in MFD carriers: First, the truncated product
would likely have no or only reduced functions on its own, since
a functionally essential domain of the protein is missing. Second,
the missplicing could reduce the stability of the truncatedMegf7/
Lrp4 mRNA, resulting in less protein overall being produced.
Either way, the data show that Megf7/Lrp4 functions would
likely be severely impaired. Taken together with the distinct
phenotype, these findings indicate that MFD is almost certainly
caused by loss-of-function mutations in the Megf7/Lrp4 gene.
Although we have found only a single point mutation that is
identical in both MFD cases belonging to the Angus cattle strain
we have been able to examine and that fully explains the
phenotype, it is possible that mutations in other Megf7 exons or
introns can also causeMFD in other strains. Such mutations may
be responsible for other cases that have been described. Over
700 independent mutations that impair the function of the LDL
receptor, a close relative and family member ofMegf7 [33], have
been found. However, in contrast to MFD, LDL receptor
mutations are phenotypically codominant, inasmuch as they
already manifest themselves in a milder form in heterozygotes,
in which they occur with a frequency of approximately 1 in 500
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simple assay that is widely used in humans further facilitates the
identification of human patients with LDL receptor defects [33].
If loss-of-function mutations occur at a similar rate in theMegf7
gene, one would thus predict a frequency of 1 case of MFD in
250,000 calves.
The nature of themutationwe have described here may explain
the variability of the phenotype among homozygous carriers of
MFD, which can range from only one to all four hooves being
affected as well as including the absence of craniofacial
dysmorphisms, which occur with incomplete penetrance in the
Megf7/Lrp4-deficient mouse [10]. The mere loss of the
cytoplasmic domain may not completely destroy the biological
function of this receptor, if the primary role of Megf7 is to
antagonize the function of one ormoremorphogens, such asWnt's
or Bmp's, at the plasma membrane. Although we did not detect
any normally spliced product in our in vitro splicing assay (Fig. 3)
or in the skin sample (Fig. 4B), individual variations in splicing
efficiency in the apical ectodermal ridge during development could
account for small amounts of functionally spliced products.
Similarly, since limb development is a complex process in which
numerous genes participate in an intricate interplay, it is highly
likely that many, if not most of these genes can act as modifiers,
i.e., they function at different levels or are regulated slightly
differently between individuals, or their function may be
epigenetically modulated to some extent. Alone or in combination,
these mechanisms may account for the observed individual
variability of MFD by effectively generating a hypomorphic
phenotype in which not all four limbs are equally malformed.
The precise mechanisms by which Megf7/Lrp4 regulates
signaling in the developing limb are now beginning to emerge.
It is clear that this LDL receptor family member can function as
a coreceptor and modulator in one or more of the morphogenic
signaling pathways we have discussed above. However, exactly
how Megf7/Lrp4 modulates these signals on the molecular
level, i.e., the precise nature of the biochemical interactions in
which it is involved, remains to be elucidated. Almost certainly
the cytoplasmic domain harbors molecular interaction motifs
that are critical for its function. The results of our yeast two-
hybrid approach (Fig. 5) will help us to define these essential
interactions and ultimately allow us to demonstrate their
importance using knock-in approaches in the mouse.
The results we have reported in this paper have identified a
splice site mutation in Megf7/Lrp4 as the cause for autosomal
recessive MFD in bovines. This is the second species after the
mouse in which naturally occurring or experimentally induced
mutations in this gene have been shown to cause syndactyly.
These findings will enable breeders to test for the presence of
MFD in their animal populations.
Experimental procedures
Genetic marker and lod scores
Positions (in cM) on bovine chromosome 15 of BMS927 and BM848 are
from the Ensembl cow database (http://www.ensembl.org). The position of
TGLA75 is from the NCBI database map viewer of bovine chromosome 15.
Positions (in Mb) for the different gene markers are from the Ensembl cowdatabase. Lod scores of BM848 and TGLA75 for the SY (mulefoot) locus are
reported in [8] using the ANIBD program.
Megf7/Lrp4 sequencing
Wild-type and mulefoot DNA samples (Angus strain) were prepared using
standard genomic DNA extraction protocols. The MF sperm sample was
obtained from bull 16ANE829 onApril 12, 1982. Briefly, approximately 200mg
tissue was digested in 1 ml of SNET buffer (20 mM Tris, pH 8.0, 5 mM EDTA,
1% SDS, 400 mM NaCl) with 200 μg of proteinase K (Roche). Tissues were
digested overnight at 55°Cwith shaking. Five hundredmicroliters of the digested
material was extracted with phenol/chloroform/isoamyl alcohol, precipitated
with 500 μl isopropanol, and redissolved in 200 μl TE (10 mM Tris–HCl,
0.1 mM EDTA, pH 7.5). Primers were designed to amplify the bovine exon
sequences including approximately 200 bp of flanking intronic sequences. Exons
4, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17, 19, 20, 21, 22, 23, 24, 26, 27, 28, 30, 31, 33,
34, 36, 37, and 38 of theMFD allele were successfully amplified, sequenced, and
compared to the reference bovineMegf7 gene sequence in the Ensembl database.
No successful PCRs were obtained from the remaining exons.
Plasmid constructs
Construction of pcAT7-SC12was essentially as described previously for SC6
[21]. pcAT7-SC12 is a β-globin minigene expression vector with CD45 exon 4
and introns inserted between exon 1 and exon 2 of the β-globin gene using NdeI
andHindIII restriction sites. Wild-type and mulefoot exon 37 and approximately
200 bp upstream and downstream flanking sequences were amplified by PCR
using primers MEJ415, 5′-GTGTGTCATATGATCCCACACTCTTCTATG-
TTCTGTTCCAC-3′, and MEJ416, 5′-GTGTGTAAGCTTAGGGCCCCTCA-
AGCTGGTCCCTCGCAAGCTG-3′. PCR products were digested with NdeI
and HindIII and cloned into pcAT7-SC12.
Transfections and RT-PCR
HEK 293 cells were cultured in six-well plates and transfected with the
indicated plasmids at 60–80% confluency. Other cell types produced similar
results (data not shown). One microgram of plasmid DNAwas transfected using
Fugene-6 transfection reagent (Roche) and the manufacturer's recommended
protocol. At the indicated times total RNA was isolated with RNA STAT-60
(Tel-Test, Inc.) from the cells using the manufacturer's recommended protocol.
RT-PCR was performed as described previously [34]. Reactions were separated
on 1.5% agarose gels. DNA bands were cut out, isolated from the gel, and
cloned into pCR4 using the TOPO Cloning Kit for Sequencing (Invitrogen) and
the manufacturer's recommended protocol.
RT-PCR analysis of MFD skin mRNA
Total RNA was extracted from wild-type and MFD tissue samples as
described above. The RT reaction was performed as recommended for the M-
MLV reverse transcriptase kit (Invitrogen). The RNAwas mixed with 500 ng of
poly(dT) oligomers (Roche) and nuclease-free water. The mixture was heated to
65°C for 5min, cooled on ice, and thenmixedwith 5× First StrandBuffer, dNTPs,
recombinant RNase inhibitor, and DTT. M-MLV reverse transcriptase was added
and reactions were incubated at 37°C for 50 min and then at 70°C for 15 min.
RNaseH (2.5U)was added to the reaction and incubated for 20min at 37°C. PCR
products were amplified using the following primers: Oligonucleotides MEJ444,
5′-CGCTGAGGAGTCCACCGATGATGTAGCTGG-3′, and MEJ445 5′-GGC-
CACATTGCCAAGATCGAACGGGCGAAC-3′, were used to amplify the exon
30 to exon 36 fragment. Oligonucleotides MEJ446, 5′-GGCCTCTGTGCGCAT-
TCCAATGAGGCCGTG-3′, and MEJ448, 5′-AGAAACAAACTCTCAGATG-
CAAGTCTTCAC-3′, were used to amplify the exon 35 to intron 37 fragment.
Yeast two-hybrid constructs
The Megf7/Lrp4 bait plasmid 2-3-4 was cloned by PCR amplification using
mouse brain cDNA and the primers MEJ9, 5′-CCATGGAGACACAGGAAATC-
CAAGTTCACGG-3′, and MEJ10, 5′-CTCGAGTTAGACCTGGCTTTCT-
GAGGAGAGCTTG-3′. The PCR product was digested with NcoI and XhoI
608 E.B. Johnson et al. / Genomics 88 (2006) 600–609and cloned into the pLexA bait plasmid. Truncated bait plasmid constructs were
constructed with the same strategy using MEJ9 and MEJ118, 5′-
GTGTGTCTCGAGCTACTGGCTTTCTGAGGAGAGCTTGCGTTCGTG-3′,
for the –V truncation and MEJ9 and MEJ43, 5′-CTCGAGCTAGGA-
GAGCTTGCGTTCGTGTTTCCAGCCTGTG-3′, for the –SESQV truncation.
Oligonucleotides MEJ107 5′-GGAAGTTCGGTAGGACGGGTTTGCA-
GCTGCCAGGTTTCCCATTCCAGGATCCGTGAACTTG-3′ and MEJ9, and
MEJ108, 5′-CCTGGAATGGGAAACCTGGCAGCTGCAAACCCCTCC-
TACCGAACTTCCACTCAGGAAG-3′ and MEJ10, respectively, were used
for PCR mutagenesis of the TYS>AAA mutant bait insert. Oligonucleotides
MEJ109 5′-CACTTCCTGAGTGGAAGTTCGTGCTGCAGCTGCGCTA-
TAGGTCAGGTTTCCCATTCCAGGATCC-3′ and MEJ120 5′-GTGT-
GTCCATGGAGACACAGGAAATCCAAGTTCACGG-3′, and MEJ110,
5′-GGAATGGGAAACCTGACCTATAGCGCAGCTGCAGCACGAACTTC-
CACTCAGGAAGTGAAACTGGA-3′ and MEJ119, 5′-GTGTGTCTCGAGT-
TAGACCTGGCTTTCTGAGGAGAGCTTG-3′, respectively, were used for
PCR mutagenesis of the NPSY>AAAA mutant bait insert. The partial products
for each mutation were combined and amplified in another PCR reaction. The
resulting PCR products were then cloned into the NcoI and XhoI sites of
pLexA.The Dab1 prey plasmid was described previously [27].
Yeast two-hybrid screen
The manufacturer's recommended protocol for the Matchmaker system
(Clontech) was followed with minor alterations and as described [27]. The yeast
strain EGY48 [p8op Lac-Z] was transformed with the wild-type Megf7/Lrp4
cytoplasmic tail bait plasmid 2-3-4 using the standard LiAc method. Cells were
grown on −Ura, −His dropout agar plates to select for transformed colonies.
Yeast were then transformed with a mouse brain cDNA library cloned into the
pB42 prey plasmid [27] using the Yeast Maker 2 system (Clontech) and plated
onto −Ura, −His, −Trp dropout agar plates to select for transformed colonies.
Colonies were pooled and plated on −Ura, −His, −Trp, −Leu dropout agar plates
containing X-gal to select for transformed colonies that expressed prey proteins
that interact with the wild-type cytoplasmic domain of mouse Megf7/Lrp4.
Positive clones were replated on −Ura, −His, −Trp, −Leu dropout agar plates
containing X-gal to confirm interactions. Prey plasmids from positive clones
were isolated as described [27], transformed into KC8 bacteria (Clontech), and
selected on −Trp dropout agar plates. Plasmids isolated from the bacterial clones
were tested for insert by restriction digest and sequencing. Interactions were
confirmed by retransforming EGY48 [p8op Lac-Z] with the wild-type Megf7/
Lrp4 bait and prey plasmids. Interactions were also confirmed by mating yeast
clone EGY48 [p8op Lac-Z] transformed with wild-type Megf7/Lrp4 bait
plasmid and yeast clone YM4271 transformed with the prey plasmid. All bait
plasmids showed minimal self-activation. Expression of all bait plasmid proteins
was confirmed by Western blot using an anti-LexA antibody.
Note added in proof
While this paper was under review, Duchesne et al.
(Genomics 88 (2006) 610–621) reported a two amino acid
substitution in exon 33 of the Megf7/Lrp4 gene in Holstein
cattle. Based on prior extensive functional analysis of the LDL
receptor gene [reviewed in 33], this mutation in an epidermal
growth factor repeat would be predicted to interfere with the
transport of the mutant Megf7/Lrp4 protein through the secretory
pathway to the cell surface, thereby severely crippling its normal
cellular functions. Taken together with the data we have
presented in this paper, these findings now provide unequivocal
evidence that mutations in Megf7/Lrp4 cause MFD in cattle.
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